Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AAF Altachem Pharma -- Ignore unavailable to you. Want to Upgrade?

To: ciderapple who wrote (32)	8/12/1999 12:24:00 PM
From: Ulster1	Read Replies (2) \| Respond to of 42

Roger, I could not agree with you more that AAF has an excellent management team on the corporate side of things. On the market side, this company has been very disappointing to me. I could have bought my entire position in the last month for less than I paid a year and a half ago. These swings do not promote long term stock holds. Had I traded this company, I could be holding twice the amount of stock I have for the same dollars. I am surprised that the company would not be doing more Investor Relations work in an effort to put some more $$$ in the till via exercised warrants before they expire. It appears that they are remedying these problems by some of the articles that you have mentioned. It is too bad that the corporate brilliance that Warren et al. exude is not mirrored in the market. Do not get me wrong, this is one of my prized holdings, but a guy likes to see his portfolio grow, not stagnate. U1

To: ciderapple who wrote (32)	9/24/1999 1:13:00 PM
From: terry	Respond to of 42

Hey Roger! Have you seen this???:-))) Assume this is you? Onwards and upwards, I hope. Must say that I used this "dip" to pick up some more at .45. Terry Altachem Pharma Ltd - Altachem hires manager of investor relations Altachem Pharma Ltd AAF Shares issued 17,646,514 1999-09-21 close $0.56 Wednesday Sep 22 1999 Mr. Warren Jackson reports Altachem Pharma has hired Roger Andrews as the manager of the investor relations department. Mr. Andrews' focus will be to expand awareness of investment opportunity, throughout the investment community. Altachem Pharma Ltd. (AAF) is a pharmaceutical company focused on manufacturing, proprietary drugs and generic drugs for global distribution. WARNING: The company relies upon litigation protection for "forward-looking" statements. (c) Copyright 1999 Canjex Publishing Ltd. canada-stockwatch.com